Smith Jeffrey T L
Officer · ZYME
As of 2026-09-16, Smith Jeffrey T L has 11 Form 4 transactions on record across 1 company — 6 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Pattern in the record: open-market sales filed in January in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.
Reconstructed holdings
- Direct $927K
- Indirect $0
| ZYME | direct | 35,334 sh | $927K |
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-12 | ZYME | Sale | 9,310 @ $22.67 | $211K | −25.8% of holding | 26,708 | Form 4 |
| 2026-01-05 | ZYME | Sale | 10,538 @ $25.10 | $264K | −36.5% of holding | 18,352 | Form 4 |
| 2025-01-06 | ZYME | Sale | 11,110 @ $14.92 | $166K | −55.5% of holding | 8,890 | Form 4 |
8 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-01-12 | ZYME | Option exercise | 17,666 | 36,018 | Form 4 |
| 2026-01-12 | ZYME | Option exercise | 17,666 | 35,334 | Form 4 |
| 2026-01-05 | ZYME | Option exercise | 20,000 | 28,890 | Form 4 |
| 2026-01-05 | ZYME | Option exercise | 20,000 | 20,000 | Form 4 |
| 2025-01-10 | ZYME | Award / grant | 53,000 | 53,000 | Form 4 |
| 2025-01-10 | ZYME | Award / grant | 79,000 | 79,000 | Form 4 |
| 2025-01-06 | ZYME | Option exercise | 20,000 | 40,000 | Form 4 |
| 2025-01-06 | ZYME | Option exercise | 20,000 | 20,000 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.